166 related articles for article (PubMed ID: 34769278)
1. IL-10 Signaling Elicited by Nivolumab-Induced Activation of the MAP Kinase Pathway Does Not Fully Contribute to Nivolumab-Modulated Heterogeneous T Cell Responses.
Harper TA; Bacot SM; Fennell CJ; Matthews RL; Zhu C; Yue P; Benton A; Friedman D; Akue A; KuKuruga MA; Lee S; Wang T; Feldman GM
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769278
[TBL] [Abstract][Full Text] [Related]
2. BRAF and MEK inhibitors differentially affect nivolumab-induced T cell activation by modulating the TCR and AKT signaling pathways.
Yue P; Harper T; Bacot SM; Chowdhury M; Lee S; Akue A; Kukuruga MA; Wang T; Feldman GM
Oncoimmunology; 2019; 8(1):e1512456. PubMed ID: 30546949
[TBL] [Abstract][Full Text] [Related]
3. p38 Mitogen-activated protein kinase/signal transducer and activator of transcription-3 pathway signaling regulates expression of inhibitory molecules in T cells activated by HIV-1-exposed dendritic cells.
Che KF; Shankar EM; Muthu S; Zandi S; Sigvardsson M; Hinkula J; Messmer D; Larsson M
Mol Med; 2012 Oct; 18(1):1169-82. PubMed ID: 22777388
[TBL] [Abstract][Full Text] [Related]
4. Exploring the Potential Use of a PBMC-Based Functional Assay to Identify Predictive Biomarkers for Anti-PD-1 Immunotherapy.
Bacot SM; Harper TA; Matthews RL; Fennell CJ; Akue A; KuKuruga MA; Lee S; Wang T; Feldman GM
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33261003
[TBL] [Abstract][Full Text] [Related]
5. IL-18 activates STAT3 in the natural killer cell line 92, augments cytotoxic activity, and mediates IFN-gamma production by the stress kinase p38 and by the extracellular regulated kinases p44erk-1 and p42erk-21.
Kalina U; Kauschat D; Koyama N; Nuernberger H; Ballas K; Koschmieder S; Bug G; Hofmann WK; Hoelzer D; Ottmann OG
J Immunol; 2000 Aug; 165(3):1307-13. PubMed ID: 10903731
[TBL] [Abstract][Full Text] [Related]
6. IL-2 activation of NK cells: involvement of MKK1/2/ERK but not p38 kinase pathway.
Yu TK; Caudell EG; Smid C; Grimm EA
J Immunol; 2000 Jun; 164(12):6244-51. PubMed ID: 10843677
[TBL] [Abstract][Full Text] [Related]
7. A specific inhibitor of the p38 mitogen activated protein kinase affects differentially the production of various cytokines by activated human T cells: dependence on CD28 signaling and preferential inhibition of IL-10 production.
Koprak S; Staruch MJ; Dumont FJ
Cell Immunol; 1999 Mar; 192(2):87-95. PubMed ID: 10087176
[TBL] [Abstract][Full Text] [Related]
8. Role of the phosphatidylinositol 3 kinase-Akt pathway in the regulation of IL-10 and IL-12 by Porphyromonas gingivalis lipopolysaccharide.
Martin M; Schifferle RE; Cuesta N; Vogel SN; Katz J; Michalek SM
J Immunol; 2003 Jul; 171(2):717-25. PubMed ID: 12847238
[TBL] [Abstract][Full Text] [Related]
9. STAT3 signaling contributes to the high effector activities of interleukin-15-derived dendritic cells.
Okada S; Han S; Patel ES; Yang LJ; Chang LJ
Immunol Cell Biol; 2015; 93(5):461-71. PubMed ID: 25582338
[TBL] [Abstract][Full Text] [Related]
10. IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT.
Tsuji-Takayama K; Suzuki M; Yamamoto M; Harashima A; Okochi A; Otani T; Inoue T; Sugimoto A; Motoda R; Yamasaki F; Nakamura S; Kibata M
Exp Hematol; 2008 Feb; 36(2):181-92. PubMed ID: 18023521
[TBL] [Abstract][Full Text] [Related]
11. 15-deoxy-Delta 12,14-PGJ2 induces IL-8 production in human T cells by a mitogen-activated protein kinase pathway.
Harris SG; Smith RS; Phipps RP
J Immunol; 2002 Feb; 168(3):1372-9. PubMed ID: 11801678
[TBL] [Abstract][Full Text] [Related]
12. IFN-γ down-regulates the PD-1 expression and assist nivolumab in PD-1-blockade effect on CD8+ T-lymphocytes in pancreatic cancer.
Ding G; Shen T; Yan C; Zhang M; Wu Z; Cao L
BMC Cancer; 2019 Nov; 19(1):1053. PubMed ID: 31694582
[TBL] [Abstract][Full Text] [Related]
13. p38 mitogen-activated protein kinase regulates human T cell IL-5 synthesis.
Mori A; Kaminuma O; Miyazawa K; Ogawa K; Okudaira H; Akiyama K
J Immunol; 1999 Nov; 163(9):4763-71. PubMed ID: 10528175
[TBL] [Abstract][Full Text] [Related]
14. IL-2 triggers specific signaling pathways in human NKT cells leading to the production of pro- and anti-inflammatory cytokines.
Bessoles S; Fouret F; Dudal S; Besra GS; Sanchez F; Lafont V
J Leukoc Biol; 2008 Jul; 84(1):224-33. PubMed ID: 18456817
[TBL] [Abstract][Full Text] [Related]
15. Residual type 1 immunity in patients genetically deficient for interleukin 12 receptor beta1 (IL-12Rbeta1): evidence for an IL-12Rbeta1-independent pathway of IL-12 responsiveness in human T cells.
Verhagen CE; de Boer T ; Smits HH; Verreck FA; Wierenga EA; Kurimoto M; Lammas DA; Kumararatne DS; Sanal O; Kroon FP; van Dissel JT ; Sinigaglia F; Ottenhoff TH
J Exp Med; 2000 Aug; 192(4):517-28. PubMed ID: 10952721
[TBL] [Abstract][Full Text] [Related]
16. Early immune response and regulation of IL-2 receptor subunits.
Hughes-Fulford M; Sugano E; Schopper T; Li CF; Boonyaratanakornkit JB; Cogoli A
Cell Signal; 2005 Sep; 17(9):1111-24. PubMed ID: 15993752
[TBL] [Abstract][Full Text] [Related]
17. Differential activation of T cell cytokine production by the extracellular signal-regulated kinase (ERK) signaling pathway.
Egerton M; Fitzpatrick DR; Catling AD; Kelso A
Eur J Immunol; 1996 Oct; 26(10):2279-85. PubMed ID: 8898934
[TBL] [Abstract][Full Text] [Related]
18. ETP-46321, a dual p110α/δ class IA phosphoinositide 3-kinase inhibitor modulates T lymphocyte activation and collagen-induced arthritis.
Aragoneses-Fenoll L; Montes-Casado M; Ojeda G; Acosta YY; Herranz J; Martínez S; Blanco-Aparicio C; Criado G; Pastor J; Dianzani U; Portolés P; Rojo JM
Biochem Pharmacol; 2016 Apr; 106():56-69. PubMed ID: 26883061
[TBL] [Abstract][Full Text] [Related]
19. PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer.
Zhang X; Zeng Y; Qu Q; Zhu J; Liu Z; Ning W; Zeng H; Zhang N; Du W; Chen C; Huang JA
Int J Clin Oncol; 2017 Dec; 22(6):1026-1033. PubMed ID: 28748356
[TBL] [Abstract][Full Text] [Related]
20. Differential impact of PD-1 and/or interleukin-10 blockade on HIV-1-specific CD4 T cell and antigen-presenting cell functions.
Porichis F; Hart MG; Zupkosky J; Barblu L; Kwon DS; McMullen A; Brennan T; Ahmed R; Freeman GJ; Kavanagh DG; Kaufmann DE
J Virol; 2014 Mar; 88(5):2508-18. PubMed ID: 24352453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
